A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer

  • Zefei Jiang
  • , Quchang Ouyang
  • , Tao Sun
  • , Qingyuan Zhang
  • , Yuee Teng
  • , Jiuwei Cui
  • , Haibo Wang
  • , Yongmei Yin
  • , Xiaojia Wang
  • , Xin Zhou
  • , Yongsheng Wang
  • , Gang Sun
  • , Jingfen Wang
  • , Lili Zhang
  • , Jin Yang
  • , Jun Qian
  • , Min Yan
  • , Xinlan Liu
  • , Tienan Yi
  • , Ying Cheng
  • Man Li, Aimin Zang, Shusen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yiding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yueyin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)421-429
Number of pages9
JournalFuture Oncology
Volume21
Issue number4
DOIs
StatePublished - 1 Feb 2025
Externally publishedYes

Cite this